BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

162 related articles for article (PubMed ID: 16814950)

  • 1. Continuing evidence for poorer treatment outcomes for single male patients: retreatment data from RTOG 97-14.
    Konski A; Desilvio M; Hartsell W; Watkins-Bruner D; Coyne J; Scarantino C; Janjan N
    Int J Radiat Oncol Biol Phys; 2006 Sep; 66(1):229-33. PubMed ID: 16814950
    [TBL] [Abstract][Full Text] [Related]  

  • 2. 8 Gy single fraction radiotherapy for the treatment of metastatic skeletal pain: randomised comparison with a multifraction schedule over 12 months of patient follow-up. Bone Pain Trial Working Party.
    Radiother Oncol; 1999 Aug; 52(2):111-21. PubMed ID: 10577696
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Randomized trial of short- versus long-course radiotherapy for palliation of painful bone metastases.
    Hartsell WF; Scott CB; Bruner DW; Scarantino CW; Ivker RA; Roach M; Suh JH; Demas WF; Movsas B; Petersen IA; Konski AA; Cleeland CS; Janjan NA; DeSilvio M
    J Natl Cancer Inst; 2005 Jun; 97(11):798-804. PubMed ID: 15928300
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Single fraction radiotherapy is efficacious: a further analysis of the Dutch Bone Metastasis Study controlling for the influence of retreatment.
    van der Linden YM; Lok JJ; Steenland E; Martijn H; van Houwelingen H; Marijnen CA; Leer JW;
    Int J Radiat Oncol Biol Phys; 2004 Jun; 59(2):528-37. PubMed ID: 15145173
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Patients with a favourable prognosis are equally palliated with single and multiple fraction radiotherapy: results on survival in the Dutch Bone Metastasis Study.
    van der Linden YM; Steenland E; van Houwelingen HC; Post WJ; Oei B; Marijnen CA; Leer JW;
    Radiother Oncol; 2006 Mar; 78(3):245-53. PubMed ID: 16545474
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Randomized trial of 8 Gy in 1 versus 20 Gy in 5 fractions of radiotherapy for neuropathic pain due to bone metastases (Trans-Tasman Radiation Oncology Group, TROG 96.05).
    Roos DE; Turner SL; O'Brien PC; Smith JG; Spry NA; Burmeister BH; Hoskin PJ; Ball DL;
    Radiother Oncol; 2005 Apr; 75(1):54-63. PubMed ID: 15878101
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Clinical features and prognostic factors in patients with bone metastases from hepatocellular carcinoma receiving external beam radiotherapy.
    He J; Zeng ZC; Tang ZY; Fan J; Zhou J; Zeng MS; Wang JH; Sun J; Chen B; Yang P; Pan BS
    Cancer; 2009 Jun; 115(12):2710-20. PubMed ID: 19382203
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Randomized clinical trial with two palliative radiotherapy regimens in painful bone metastases: 30 Gy in 10 fractions compared with 8 Gy in single fraction.
    Foro Arnalot P; Fontanals AV; Galcerán JC; Lynd F; Latiesas XS; de Dios NR; Castillejo AR; Bassols ML; Galán JL; Conejo IM; López MA
    Radiother Oncol; 2008 Nov; 89(2):150-5. PubMed ID: 18556080
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Prospective randomised multicenter trial on single fraction radiotherapy (8 Gy x 1) versus multiple fractions (3 Gy x 10) in the treatment of painful bone metastases.
    Kaasa S; Brenne E; Lund JA; Fayers P; Falkmer U; Holmberg M; Lagerlund M; Bruland O
    Radiother Oncol; 2006 Jun; 79(3):278-84. PubMed ID: 16793154
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Posttreatment prostatic-specific antigen doubling time as a surrogate endpoint for prostate cancer-specific survival: an analysis of Radiation Therapy Oncology Group Protocol 92-02.
    Valicenti RK; DeSilvio M; Hanks GE; Porter A; Brereton H; Rosenthal SA; Shipley WU; Sandler HM;
    Int J Radiat Oncol Biol Phys; 2006 Nov; 66(4):1064-71. PubMed ID: 16979837
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effect of education level on outcome of patients treated on Radiation Therapy Oncology Group Protocol 90-03.
    Konski A; Berkey BA; Kian Ang K; Fu KK
    Cancer; 2003 Oct; 98(7):1497-503. PubMed ID: 14508838
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Reirradiation with local-field radiotherapy for painful bone metastases.
    Hayashi S; Hoshi H; Iida T
    Radiat Med; 2002; 20(5):231-6. PubMed ID: 12450102
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Whole-brain radiotherapy with 20 Gy in 5 fractions for brain metastases in patients with cancer of unknown primary (CUP).
    Rades D; Bohlen G; Lohynska R; Veninga T; Stalpers LJ; Schild SE; Dunst J
    Strahlenther Onkol; 2007 Nov; 183(11):631-6. PubMed ID: 17960339
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Pretreatment factors significantly influence quality of life in cancer patients: a Radiation Therapy Oncology Group (RTOG) analysis.
    Movsas B; Scott C; Watkins-Bruner D
    Int J Radiat Oncol Biol Phys; 2006 Jul; 65(3):830-5. PubMed ID: 16564646
    [TBL] [Abstract][Full Text] [Related]  

  • 15. International patterns of practice in palliative radiotherapy for painful bone metastases: evidence-based practice?
    Fairchild A; Barnes E; Ghosh S; Ben-Josef E; Roos D; Hartsell W; Holt T; Wu J; Janjan N; Chow E
    Int J Radiat Oncol Biol Phys; 2009 Dec; 75(5):1501-10. PubMed ID: 19464820
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Survival status of stage IV non-small cell lung cancer patients after radiotherapy--a report of 287 cases].
    Cai Y; Wang WL; Xu B; Zhu GY; Zhang SW
    Ai Zheng; 2006 Nov; 25(11):1419-22. PubMed ID: 17094913
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The management of painful bone metastases with biphosphonates and palliative radiotherapy: a retrospective evaluation of 372 cases.
    Niang U; Kamer S; Ozsaran Z; Haydaroglu A; Kilciksiz S
    J BUON; 2009; 14(2):245-9. PubMed ID: 19650174
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Long-term follow-up of cancer patients receiving radiotherapy for bone metastases: results from a randomised multicentre trial.
    Sande TA; Ruenes R; Lund JA; Bruland OS; Hornslien K; Bremnes R; Kaasa S
    Radiother Oncol; 2009 May; 91(2):261-6. PubMed ID: 19307034
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Comparison of short-course versus long-course whole-brain radiotherapy in the treatment of brain metastases.
    Rades D; Bohlen G; Dunst J; Lohynska R; Veninga T; Stalpers L; Schild SE; Dahm-Daphi J
    Strahlenther Onkol; 2008 Jan; 184(1):30-5. PubMed ID: 18188520
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Evaluation of 2 whole-brain radiotherapy schedules and prognostic factors for brain metastases in breast cancer patients.
    Rades D; Lohynska R; Veninga T; Stalpers LJ; Schild SE
    Cancer; 2007 Dec; 110(11):2587-92. PubMed ID: 17893909
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.